Foghorn Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FHTX and other ETFs, options, and stocks.About FHTX
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.
CEOAdrian Gottschalk
CEOAdrian Gottschalk
Employees112
Employees112
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees112
Employees112
FHTX Key Statistics
Market cap246.56M
Market cap246.56M
Price-Earnings ratio-3.67
Price-Earnings ratio-3.67
Dividend yield—
Dividend yield—
Average volume153.94K
Average volume153.94K
High today—
High today—
Low today—
Low today—
Open price$4.63
Open price$4.63
Volume0.00
Volume0.00
52 Week high$6.81
52 Week high$6.81
52 Week low$2.94
52 Week low$2.94
Stock Snapshot
Foghorn Therapeutics(FHTX) stock is priced at $4.36, giving the company a market capitalization of 246.56M. It carries a P/E multiple of -3.67.
On 2025-12-08, Foghorn Therapeutics(FHTX) shares started trading at $4.63, with intraday highs of — and lows of —.
Trading volume for Foghorn Therapeutics(FHTX) stock has reached 0, versus its average volume of 153.94K.
The stock's 52-week range extends from a low of $2.94 to a high of $6.81.
The stock's 52-week range extends from a low of $2.94 to a high of $6.81.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own FHTX. This list is generated using Robinhood data, and it’s not a recommendation.